Keyword [Tkis] Result: 161 - 180 | Page: 9 of 10 161.  Effect Analysis Of EGFR-TKIs Or Chemotherapy Combined With Radiotherapy In The Treatment Of Brain Metastases Of EGFR Mutant Non-small Cell Lung Cancer 162.  The Mechanism Of EGFR-TKIs Resistance In HOTAIR In Non-small Cell Lung Cancer 163.  The Investigation About EZH2 Inhibitor Combined With Gefitinib In EGFR-TKIs Resistant Lung Cancer 164.  Prognostic Values Of Clinical Parameters Of Stage ? NSCLC Patients Treated With First-line EGFR-TKIs 165.  Model To Predict PFS Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Chinese Han Lung Adenocarcinoma Population 166.  Retrospective Study Of Advanced NSCLC Chinese Patients With EGFR Mutation-positive Treated With Osimertinib 167.  Correlation Between Clinical Features Of Patients With Advanced NSCLC After The First Generation EGFR-TKIS Resistance And T790M Mutation,the Efficacy Of Osimertinib 168.  The Molecular Mechanism Of TKIs-Biomechanics Tuning The Interaction Of PD-1 And PD-L1 169.  Study On The Efficacy And Safety Of EGFR-TKIs Combined With Whole Brain Radiotherapy In Brain Metastasis Of Lung Adenocarcinoma 170.  Analysis Of The Efficacy And Prognosis Of Different Treatment For Driver Gene Mutations Non-small Cell Lung Cancer With Multiple Brain Metastases 171.  The Epidemiological Investigation And Clinical Observation Of XXXX01 For The Treatment Of The Rash Caused By EGFR-TKIs In NSCLC 172.  MiR-335-3p Affects The Sensitivity Of NSCLC Cells To Gefitinib And Cell Proliferation,migration And Invasion 173.  The Role Of PD-L1 In Primary Resistance To EGFR-TKIs And Its Mechanism In Non-small Cell Lung Cancer 174.  Effect Of Combined EGFR Inhibitor On Chemosensitivity Of Gastric Cancer AGS Cells With Cisplatin 175.  Clinicopathological Features And Prognosis Of Brain Metastasis Of Lung Adenocarcinoma With EGFR Mutation 176.  Clinical Observation Of Xiao Zhen Tang On EGFR-TKIs Related Rash(Yin Deficiency Type) Of Lung Adenocarcinoma 177.  Meta-analysis Of EGFR-TKIs In EGFR-mutant Non-small Cell Lung Cancer Patients And Clinical Retrospective Validation 178.  The Systematic Review Of Traditional Chinese Medicine Combined With EGFR-TKIs In The Treatment Of Middle To Late Stage Non-small-cell Lung Carcinoma With EGFR Mutations 179.  Relationship Between Inflammatory Markers And Prognosis In Advanced Non-small Cell Lung Cancer Patients Treated With First-Line EGFR-TKIs 180.  Comparison Of The Efficacy Between Auto-HSCT And Allo-HSCT Combined With TKIs For Patients With Ph+ALL:A Meta Analysis   <<First  <Prev  Next>  Last>>  Jump to

Globe Thesis Copyright © 2023. All Rights Reserved. | Privacy | Copyright | Contribute | About | Contact | RSS